These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12086567)

  • 21. Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.
    Agarwal V; Kumar P
    J Clin Psychiatry; 2001 Apr; 62(4):298-9. PubMed ID: 11379849
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversal of rabbit syndrome with olanzapine.
    Damodaran SS; Thankamma JK
    Aust N Z J Psychiatry; 2000 Feb; 34(1):172-3. PubMed ID: 11185940
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between olanzapine and haloperidol.
    Gomberg RF
    J Clin Psychopharmacol; 1999 Jun; 19(3):272-3. PubMed ID: 10350035
    [No Abstract]   [Full Text] [Related]  

  • 24. [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study].
    Sacristán JA; Gómez JC; Ferre F; Gascón J; Pérez Bravo A; Olivares JM
    Actas Esp Psiquiatr; 2001; 29(1):25-32. PubMed ID: 11333516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Side effect profiles of new antipsychotic agents.
    Casey DE
    J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L; Lavalaye J; Linszen D; Dingemans PM; Booij J
    Am J Psychiatry; 2000 Jun; 157(6):1019-20. PubMed ID: 10831489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety in treating bipolar disorder.
    Gupta S
    J Fam Pract; 2003 Mar; Suppl():S26-9. PubMed ID: 12676082
    [No Abstract]   [Full Text] [Related]  

  • 28. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine-induced reversible priaprism: a case report.
    Deirmenjian JM; Erhart SM; Wirshing DA; Spellberg BJ; Wirshing WC
    J Clin Psychopharmacol; 1998 Aug; 18(4):351-3. PubMed ID: 9690708
    [No Abstract]   [Full Text] [Related]  

  • 30. Side Effects of Antipsychotic Medications: Physician's Choice of Medication and Patient Compliance. Dallas, Texas, California. January 22, 1999. Proceedings of a roundtable.
    J Clin Psychiatry; 2000; 61 Suppl 8():3-66; quiz 67-70. PubMed ID: 10811236
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient.
    Meyer JM; Marsh J; Simpson G
    Biol Psychiatry; 1998 Oct; 44(8):791-4. PubMed ID: 9798086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
    Feldman PD; Hay LK; Deberdt W; Kennedy JS; Hutchins DS; Hay DP; Hardy TA; Hoffmann VP; Hornbuckle K; Breier A
    J Am Med Dir Assoc; 2004; 5(1):38-46. PubMed ID: 14706127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF
    Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract]   [Full Text] [Related]  

  • 34. Tardive dyskinesia from risperidone and olanzapine in an alcoholic man.
    Snoddgrass PL; Labbate LA
    Can J Psychiatry; 1999 Nov; 44(9):921. PubMed ID: 10584163
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.
    Bronson BD; Lindenmayer JP
    J Clin Psychopharmacol; 2000 Jun; 20(3):382-4. PubMed ID: 10831029
    [No Abstract]   [Full Text] [Related]  

  • 36. The relationship of pharmacology to side effects.
    Casey DE
    J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 38. The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.
    Caro JJ; Ward A; Levinton C; Robinson K
    J Clin Psychiatry; 2002 Dec; 63(12):1135-9. PubMed ID: 12523873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine-induced mania in bipolar disorders.
    Henry C; Demotes-Mainard J
    J Psychiatry Neurosci; 2002 May; 27(3):200-1. PubMed ID: 12066449
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.